HomeBiotech

Biotech

Biotech

Syntis Bio Reports Phase 1/1b Data for Oral Obesity Drug SYNT-101

Life Sciences Times - 0
Biotech

Sensorion Completes 50-for-1 Reverse Share Split

Life Sciences Times - 0
Biotech

Enveric Biosciences Secures U.S. Patent Allowance for Non-Hallucinogenic Mescaline Derivatives

Life Sciences Times - 0
Biotech

FDA Approves Scholar Rock’s Isembyld for Spinal Muscular Atrophy

Life Sciences Times - 0
Biotech

Zipalertinib Plus Chemotherapy Improves Progression-Free Survival in EGFR-Mutant Lung Cancer Trial

Life Sciences Times - 0
Biotech

Lysoway Therapeutics Reports Preclinical Data for TRPML1 Agonist LW-1017

Life Sciences Times - 0
Biotech

Biomunex Says FDA Review Completed for IPN60330 Ahead of Phase 1 Trial

Life Sciences Times - 0
Biotech

Alloy Therapeutics Named to Fast Company’s 2026 Best Workplaces for Innovators List

Life Sciences Times - 0
Biotech

Bionyra Pharma Doses First Volunteers in Phase 1 Study of BYN-001

Life Sciences Times - 0
Biotech

Ride Therapeutics Secures Up to $7.3 Million from Cystic Fibrosis Foundation

Life Sciences Times - 0
Biotech

TRIANA Biomedicines Publishes Preclinical Data Supporting TRI-611 Development

Life Sciences Times - 0
Biotech

Ginkgo Bioworks Joins ARPA-H Program to Develop Automated RNA Medicine Manufacturing System

Life Sciences Times - 0
123...112Page 1 of 112

Most Read